TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32144925

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-scalp acupuncture
Number of subjects: 18
Study: 35340008

Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (mimic TT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (regular routine care)
Number of subjects: 0
Study: 34321304

Group type: EXPERIMENTAL
Intervention: Dural sealant patch (DSP)
Number of subjects: 40
Study: 37480877

Group type: EXPERIMENTAL
Intervention: Atrial shunt therapy (Corvia Medical, Inc IASD System II)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Baseline AF burden ≥0.012%
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Adjustment for left atrial reservoir strain
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Patch-detected AF during follow-up
Number of subjects: 367
Study: 35049677

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) (36.25 Gy/5 fractions/2 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (CFRT) (76 Gy/38 fractions/7.5 weeks)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (CFRT)
Number of subjects: 64
Study: 32777060

Group type: EXPERIMENTAL
Intervention: Heart team recommendations
Number of subjects: 237
Study: 616168499

Group type: EXPERIMENTAL
Intervention: Nefopam (0.3 mg/kg bolus followed by continuous infusion at 65 micro g/kg/h)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamine (0.3 mg/kg bolus followed by continuous infusion at 180 micro g/kg/h)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (bolus and infusion equal to ketamine group)
Number of subjects: 60
Study: 36126454

Group type: EXPERIMENTAL
Intervention: Afatinib (30 mg or 40 mg) without PPI (period A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Afatinib (30 mg or 40 mg) with 40 mg esomeprazole (period B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Afatinib (30 mg or 40 mg) three hours after esomeprazole intake (period C)
Number of subjects: 18
Study: 33315169

Group type: EXPERIMENTAL
Intervention: Short-term dual antiplatelet therapy (DAPT) (at most 6 months)
Number of subjects: 7142

Group type: COMPARATOR
Intervention: Long-term dual antiplatelet therapy (DAPT) (at least 12 months)
Number of subjects: 7142
Study: 33447025

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol 100/25 μg once daily
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Intermountain Risk Score (IMRS) tertiles
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Summit Lab Score tertiles
Number of subjects: 430
Study: 32738409

Group type: EXPERIMENTAL
Intervention: aDBS
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: cDBS
Number of subjects: 13

Group type: COMPARATOR
Intervention: NoStim
Number of subjects: 13
Study: 34662548

Group type: EXPERIMENTAL
Intervention: Sbv + topical BC bio-curatives
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sbv alone
Number of subjects: 20
Study: 33781794

Group type: EXPERIMENTAL
Intervention: Health technology education program plus focus groups and routine shared care
Number of subjects: 108

Group type: COMPARATOR
Intervention: Routine shared care
Number of subjects: 108
Study: 35833676

Group type: EXPERIMENTAL
Intervention: Trauma Center Trauma-Sensitive Yoga (TCTSY), 10 weekly sessions
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT), 12 weekly sessions
Number of subjects: 41
Study: 33826757

Group type: EXPERIMENTAL
Intervention: Incense smoke exposure (exposed group, n = 45)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (n = 80)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Incense smoke exposure
Number of subjects: 125
Study: 34221251

Group type: EXPERIMENTAL
Intervention: 3MDR therapy
Number of subjects: 37
Study: 32474728

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 110 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 150 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (both doses)
Number of subjects: 28
Study: 35206394

Group type: EXPERIMENTAL
Intervention: Tailored online parenting programme ('Parenting Resilient Kids'; PaRK)
Number of subjects: 177
Study: 34678740

Group type: EXPERIMENTAL
Intervention: Alloy Primer
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ea‐Z‐y Primer
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CoJet Sand
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (air abrasion with 50‐μm alumina particles)
Number of subjects: 24
Study: 32941476

Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 42

Group type: COMPARATOR
Intervention: Protease inhibitor (PI)
Number of subjects: 42
Study: 35091036

Group type: EXPERIMENTAL
Intervention: Intraosseous regional administration (IORA) of 500 mg vancomycin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous (IV) administration of weight-based (15 mg/kg) vancomycin
Number of subjects: 24
Study: 34711835

Group type: EXPERIMENTAL
Intervention: REHACOP (integrative cognitive remediation program)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Active control (occupational activities)
Number of subjects: 94
Study: 36032232

Group type: EXPERIMENTAL
Intervention: Taijiquan combined with acupoint pressing (treatment before sleep)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Taijiquan combined with acupoint pressing (treatment after sleep)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Regular psychological counseling (control group)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Taijiquan combined with acupoint pressing (both treatment groups)
Number of subjects: 126
Study: 34020450

Group type: EXPERIMENTAL
Intervention: Lesser mealworm-derived protein
Number of subjects: 24

Group type: COMPARATOR
Intervention: Milk-derived protein
Number of subjects: 24
Study: 35139161

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin withdrawal (placebo)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuation of intravenous immunoglobulin treatment (control)
Number of subjects: 60
Study: 33772900

Group type: EXPERIMENTAL
Intervention: Supervised community physical activity for 9 months
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Stopped exercise at 9 months
Number of subjects: 28
Study: 33141327

Group type: EXPERIMENTAL
Intervention: Group handwashing facilities and daily group handwashing and toothbrushing activities
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 20
Study: 35191268

Group type: EXPERIMENTAL
Intervention: Micro needle knife therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Traditional acupuncture
Number of subjects: 300

Group type: COMPARATOR
Intervention: Oral drug (Merislon, 6 mg, 3 times a day for 2 weeks)
Number of subjects: 300
Study: 34252916

Group type: EXPERIMENTAL
Intervention: MaxiPost (BKCa channel opener)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 35123457

Group type: COMPARATOR
Intervention: Fixed-dose inhaled corticosteroids (ICS) as control
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Taper and subsequently stop ICS
Number of subjects: 120
Study: 33063909

Group type: EXPERIMENTAL
Intervention: PB-TURSO
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 35332685

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) additional over inspiratory muscle training (IMT) at 40% of maximal inspiratory pressure (MIP) for 12 weeks (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inspiratory muscle training (IMT) alone for 12 weeks (n = 30)
Number of subjects: 60
Study: 33663463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 32423730

Group type: EXPERIMENTAL
Intervention: CPAP 10 cmH20 on deflated lung
Number of subjects: 22

Group type: COMPARATOR
Intervention: NO CPAP
Number of subjects: 22
Study: 34924346

Group type: EXPERIMENTAL
Intervention: TranS-C
Number of subjects: 118

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 118
Study: 33010649

Group type: EXPERIMENTAL
Intervention: Stress ball intervention (squeezing a stress ball for 10-15 minutes during eight dialysis sessions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no stress ball intervention)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Stress ball intervention
Number of subjects: 45
Study: 35468019

Group type: EXPERIMENTAL
Intervention: CT Colonography Screening (Intervention)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Arm (Control)
Number of subjects: 21
Study: 36223397

Group type: EXPERIMENTAL
Intervention: Aquatic exercise group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Land exercise group
Number of subjects: 44
Study: 33885738

Group type: EXPERIMENTAL
Intervention: Pneumatic retinopexy (PnR)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 150
Study: 33109137

Group type: EXPERIMENTAL
Intervention: Housewives
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Perceived low economic status
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Lack of partner support
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Unplanned pregnancy
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Maternal illness after delivery
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Residing in Southwest‐Asmara
Number of subjects: 380
Study: 36273151

Group type: EXPERIMENTAL
Intervention: Use of an evidence-based decision tool for prioritizing preventive services
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 600
Study: 34365905

Group type: EXPERIMENTAL
Intervention: Low dose GOS (10-15 grams/day)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: High dose GOS (15-20 grams/day)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: GOS (both doses)
Number of subjects: 377
Study: 35597066

Group type: EXPERIMENTAL
Intervention: Citalopram (225 patients), titrated according to clinical response
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo (215 patients)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Citalopram (225 patients)
Number of subjects: 440
Study: 34587382

Group type: EXPERIMENTAL
Intervention: AZD1222 (ChAdOx1 nCoV-19) vaccine
Number of subjects: 32451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32451
Study: 35670987

Group type: EXPERIMENTAL
Intervention: Triggered escalating real‐time adherence (TERA) intervention with remote coaching, electronic dose monitoring (EDM), and outreach for missed/delayed doses
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: TERA
Number of subjects: 89

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 89
Study: 32503806

Group type: EXPERIMENTAL
Intervention: Simplified treatment schedules, telemedicine facilitation, decreased data collection requirements
Number of subjects: 0
Study: 34568490

Group type: EXPERIMENTAL
Intervention: One-fifth of bodyweight traction
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: One-third of bodyweight traction
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: One-half of bodyweight traction
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study: 32381097

Group type: EXPERIMENTAL
Intervention: Home-visiting program
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Center-based parenting groups
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control areas (not receiving intervention initially)
Number of subjects: 39
Study: 35922771

Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120
Study: 33720997

Group type: EXPERIMENTAL
Intervention: Daily SMS reminders about insulin injections
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 92
Study: 32709172

Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided Erector Spinae Plane (ESP) block with 20 mL of bupivacaine 0.375% plus 5 ug/mL adrenaline (1:200000)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided Erector Spinae Plane (ESP) block
Number of subjects: 48

Group type: COMPARATOR
Intervention: Bilateral ultrasound-guided Transversus Abdominis Plane (TAP) block
Number of subjects: 48
Study: 616681315

Group type: EXPERIMENTAL
Intervention: 7‐d PUFA‐rich diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 26
Study: 34817667

Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication reconciliation at hospital admission
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 120
Study: 33486475

Group type: EXPERIMENTAL
Intervention: IVC ultrasonography-guided hydration
Number of subjects: 207

Group type: COMPARATOR
Intervention: Standard hydration (0.9% saline at 0.5 mL/(kg·h))
Number of subjects: 207
Study: 32105310

Group type: EXPERIMENTAL
Intervention: Fecal calprotectin (FC) <250 µg/g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRP <5 mg/L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fecal calprotectin <250 µg/g, CRP <5 mg/L, and CDAI <150
Number of subjects: 0
Study: 33651728

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (BIC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study: 32236400

Group type: EXPERIMENTAL
Intervention: TEAM‐V Program
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study: 35313276

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery™ (ER)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dietary intake of N3-rich foods and supplement compliance
Number of subjects: 25
Study: 32014809

Group type: EXPERIMENTAL
Intervention: 6-week CBT-I program
Number of subjects: 33

Group type: COMPARATOR
Intervention: 6-week active control
Number of subjects: 33

Group type: COMPARATOR
Intervention: Single session of sleep education
Number of subjects: 33
Study: 33814320

Group type: EXPERIMENTAL
Intervention: Nasal high-flow therapy (NHFT)
Number of subjects: 23
Study: 33046533

Group type: EXPERIMENTAL
Intervention: 4-base pair core-enclosing helix (CEH)
Number of subjects: 1157

Group type: COMPARATOR
Intervention: ΔCEH, 1-bp, and 2-bp alleles
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: 4-bp CEH RNA
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Shorter-CEH constructs
Number of subjects: 1157
Study: 35135495

Group type: EXPERIMENTAL
Intervention: Hybrid learning method (distance learning and small group peer-to-peer simulation training sessions with remote supervision)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hybrid learning method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional simulation learning (lectures and classic simulation-based training)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional simulation learning
Number of subjects: 100
Study: 34298005

Group type: EXPERIMENTAL
Intervention: Prenatal household air pollution exposure (measured by carbon monoxide, CO)
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Postnatal household air pollution exposure (measured by carbon monoxide, CO)
Number of subjects: 1414
Study: 32357107

Group type: EXPERIMENTAL
Intervention: SDLMI + Whose Future Is It? (SDLMI + WF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self‐Determined Learning Model of Instruction (SDLMI) only
Number of subjects: 0
Study: 35840297

Group type: EXPERIMENTAL
Intervention: Collaborative shared care follow-up with GPs (supported by online outcome monitoring) for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-directed screening and education about post-intensive care syndrome and child development
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collaborative shared care follow-up with GPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-directed screening and education
Number of subjects: 0
Study: 34551998

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD‐MTX) 15-20 mg/week
Number of subjects: 4786

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4786

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD‐MTX)
Number of subjects: 4786
Study: 34729823

Group type: EXPERIMENTAL
Intervention: Behavioral Activation with Mental Imagery (BA‐MI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Attention‐Assessment control
Number of subjects: 41
Study: 32565333

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg taken 1 hour before treatment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nonibuprofen (no analgesics taken before treatment)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (4 patients undergoing endodontic therapy for prosthodontic reasons, no analgesics)
Number of subjects: 34
Study: 35586674

Group type: EXPERIMENTAL
Intervention: Moxibustion instrument combined with ultrashort wave
Number of subjects: 84

Group type: COMPARATOR
Intervention: Moxibustion instrument
Number of subjects: 84
Study: 33314332

Group type: EXPERIMENTAL
Intervention: Microtextured implants with a 3.6mm-long internal-connection machined collar
Number of subjects: 22

Group type: COMPARATOR
Intervention: Machined implants with a 1.2mm-long external-connection machined collar
Number of subjects: 22

Group type: COMPARATOR
Intervention: Microtextured implants with a 1.2mm-long external-connection machined collar
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Internal-connection microtextured implants
Number of subjects: 22

Group type: COMPARATOR
Intervention: External-connection microtextured implants
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All implant types
Number of subjects: 22
Study: 32381373

Group type: EXPERIMENTAL
Intervention: Nicotine patch (14 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 20
Study: 32662323

Group type: EXPERIMENTAL
Intervention: Smartphone-based guided self-help
Number of subjects: 100

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 100
Study: 35251396

Group type: EXPERIMENTAL
Intervention: ERAS group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional treatment group
Number of subjects: 60
Study: 33275152

Group type: EXPERIMENTAL
Intervention: DKA episodes with AKI
Number of subjects: 1359

Group type: COMPARATOR
Intervention: DKA episodes without AKI
Number of subjects: 1359
Study: 36264177

Group type: EXPERIMENTAL
Intervention: Intra‐uterine foley's catheter
Number of subjects: 60

Group type: COMPARATOR
Intervention: Leich‐Wilkinson cannula
Number of subjects: 60
Study: 33293295

Group type: EXPERIMENTAL
Intervention: Chamas (community health volunteer-led, group-based health education programme)
Number of subjects: 1920

Group type: COMPARATOR
Intervention: Standard of care (monthly, individual CHV home visits)
Number of subjects: 1920
Study: 35191654

Group type: EXPERIMENTAL
Intervention: Medium-energy rESWT (mrESWT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High-energy rESWT (hrESWT)
Number of subjects: 39
Study: 34384821

Group type: EXPERIMENTAL
Intervention: ECPR
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Conventional Resuscitation
Number of subjects: 308
Study: 32214373

Group type: EXPERIMENTAL
Intervention: Personalized metabolism-informed care (MIC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 32
Study: 35596182

Group type: EXPERIMENTAL
Intervention: Olaparib as maintenance therapy
Number of subjects: 639

Group type: COMPARATOR
Intervention: Newly derived reference values for treatment-naïve mPC patients
Number of subjects: 639
Study: 34530495

Group type: EXPERIMENTAL
Intervention: Individual reminiscence therapy for 8 weeks during home visits (once a week)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 65
Study: 33328172

Group type: EXPERIMENTAL
Intervention: Enhanced services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 32067533

Group type: EXPERIMENTAL
Intervention: High-dose folic acid (4.0-5.1 mg daily)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study: 34628865

Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention program
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conventional intervention
Number of subjects: 159
Study: 32442195

Group type: EXPERIMENTAL
Intervention: DNA-primed regimen
Number of subjects: 242

Group type: COMPARATOR
Intervention: ALVAC-primed regimen
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: DNA-primed regimen via Biojector
Number of subjects: 242
Study: 35410783

Group type: EXPERIMENTAL
Intervention: 1 sachet of macrogol a day, one week prior to surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: No preoperative laxatives
Number of subjects: 82
Study: 33663414

Group type: EXPERIMENTAL
Intervention: Multicomponent Training (MT) biweekly exercise sessions for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly sessions regarding physical activity and health-related topics for 6 months (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multicomponent Training (MT)
Number of subjects: 0
Study: 34716884

Group type: EXPERIMENTAL
Intervention: Online Pilates exercises conducted 3 days a week for 6 weeks, 1 hour a day.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no exercise program).
Number of subjects: 33
Study: 34124256

Group type: EXPERIMENTAL
Intervention: HIV
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: HBV
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: HCV
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: T. pallidum
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Any STI
Number of subjects: 360
Study: 35379537

Group type: EXPERIMENTAL
Intervention: Case Management with Problem-Solving Therapy (CM-PST)
Number of subjects: 56
Study: 33846747

Group type: EXPERIMENTAL
Intervention: Aneuploid embryos (n=20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Euploid embryos (n=10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Maternal age
Number of subjects: 30